Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients
<p>Abstract</p> <p>Background</p> <p>Adjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to determine risk factors for t...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-12-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/5/1/118 |